
Additional Analyses Provide Insight into Treatment Effect of VB-111 TEL AVIV, Israel, Nov. 16, ...

YONKERS, N.Y., June 14, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...
Click to continue to site. Closing